Endo Blog

Media Statement: Endometriosis Australia Responds to Comments About Endometriosis by Marty Sheargold 
2 mins read |
Media Statement: Endometriosis Australia Responds to Comments About Endometriosis by Marty Sheargold 

MEDIA STATEMENT
FOR IMMEDIATE RELEASE
27 February 2025

Endometriosis Australia is deeply disappointed by a recent comment made by Marty Sheargold, claiming that endometriosis is “made up.” This is not only factually wrong but is also dismissive of the real experiences of the one in seven (by age 49) women and those presumed female at birth who are diagnosed and live with this debilitating condition. 

Endometriosis is a chronic disease in which tissue similar to the lining of the uterus grows outside of it, causing severe pain, infertility, effects mental health and has other serious health complications. It is a scientifically recognised medical condition, supported by decades of research and acknowledged by leading health authorities worldwide, including the World Health Organization.   

The impact of endometriosis extends far beyond physical pain or “bad periods”—many individuals experience delays in diagnosis, workplace discrimination, and significant disruptions to their daily lives.  

Monica Forlano. Chair of Endometriosis Australia, said: “Dismissing their suffering as “made up” only reinforces the stigma we are working so hard to end and the misinformation contributes to the challenges women face.” 

Endometriosis Australia urge public figures to use their platforms responsibly and to educate themselves on health issues that affect so many people. Cruel comments like this are harmful and undermines the tireless work of researchers, healthcare professionals, and advocacy organisations striving to improve care and support for those affected.   

Monica Forlano. Chair of Endometriosis Australia, said: “We remain committed to raising awareness, supporting those with endometriosis, and advocating for better education and research.”  

Endometriosis Australia has an ongoing partnership with Southern Cross Austereo (SCA) to increase awareness and education about endometriosis. Through this partnership, we are working together to share accurate information, highlight real experiences, and ensure that more Australians understand the seriousness of this condition.  SCA has donated advertising and messaging to Endometriosis Australia, and this support continues. 

Endometriosis Australia welcomes organisations from any industry to enquire about our EndoAware workplace program designed to help businesses support employees with endometriosis and become accredited endo friendly workplaces. 

Endometriosis Australia encourages Marty Sheargold and others to learn more about the condition using the resources we have available on our website and across our social media platforms.    

For media inquiries, please contact:   

media@endoaustralia.org

Natalie Rupil – General Manager at Endometriosis Australia
natalie@endoaustralia.org 0434 702 080 

About Endometriosis Australia: 

Endometriosis Australia is the peak body for endometriosis in Australia. Since 2013, the organisation has been leading the charge nationally and internationally in raising awareness and understanding of endometriosis. Endometriosis Australia lobbied for and supported the development of Australia’s first National Action Plan for Endometriosis (NAPE), aimed at improving patient and medical community understanding of the disease. This was a continuation of the organisation driving the first discussion of endometriosis in Parliament in 2017.  Endometriosis Australia is a nationally accredited charity that raises awareness, educates and funds research for endometriosis. We are committed to empowering patients with the knowledge to be in control of their healthcare and promoting patient-centred care solutions. 

 

26
0

Related Blogs

About Us

Endometriosis Australia is a nationally accredited charity that endeavours to increase recognition of endometriosis, provide endometriosis education programs, and provide funding for endometriosis research.